The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
E Suder, W Furuyama, H Feldmann… - Human vaccines & …, 2018 - Taylor & Francis
The devastating Ebola virus (EBOV) epidemic in West Africa in 2013–2016 accelerated the
progress of several vaccines and antivirals through clinical trials, including the replication …
progress of several vaccines and antivirals through clinical trials, including the replication …
Ebola virus disease vaccines: development, current perspectives & challenges
The global outgoing outbreaks of Ebola virus disease (EVD) in different regions of Sudan,
Uganda, and Western Africa have brought into focus the inadequacies and restrictions of pre …
Uganda, and Western Africa have brought into focus the inadequacies and restrictions of pre …
[HTML][HTML] Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster …
Background rVSV-ZEBOV is a recombinant, replication competent vesicular stomatitis virus-
based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested …
based candidate vaccine expressing a surface glycoprotein of Zaire Ebolavirus. We tested …
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Without an approved vaccine or treatments, Ebola outbreak management has been limited
to palliative care and barrier methods to prevent transmission. These approaches, however …
to palliative care and barrier methods to prevent transmission. These approaches, however …
A recombinant vesicular stomatitis virus Ebola vaccine
JA Regules, JH Beigel, KM Paolino… - … England Journal of …, 2017 - Mass Medical Soc
Background The worst Ebola virus disease (EVD) outbreak in history has resulted in more
than 28,000 cases and 11,000 deaths. We present the final results of two phase 1 trials of an …
than 28,000 cases and 11,000 deaths. We present the final results of two phase 1 trials of an …
Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): bluetongue
EFSA Panel on Animal Health and Welfare … - Efsa …, 2017 - Wiley Online Library
A specific concept of strain was developed in order to classify the BTV serotypes ever
reported in Europe based on their properties of animal health impact: the genotype …
reported in Europe based on their properties of animal health impact: the genotype …
Structural and functional aspects of Ebola virus proteins
S Jain, E Martynova, A Rizvanov, S Khaiboullina… - Pathogens, 2021 - mdpi.com
Ebola virus (EBOV), member of genus Ebolavirus, family Filoviridae, have a non-segmented,
single-stranded RNA that contains seven genes:(a) nucleoprotein (NP),(b) viral protein 35 …
single-stranded RNA that contains seven genes:(a) nucleoprotein (NP),(b) viral protein 35 …
Marburg virus pathogenesis–differences and similarities in humans and animal models
K Shifflett, A Marzi - Virology journal, 2019 - Springer
Marburg virus (MARV) is a highly pathogenic virus associated with severe disease and
mortality rates as high as 90%. Outbreaks of MARV are sporadic, deadly, and often …
mortality rates as high as 90%. Outbreaks of MARV are sporadic, deadly, and often …
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV
SA Ehrhardt, M Zehner, V Krähling, H Cohen-Dvashi… - Nature medicine, 2019 - nature.com
Recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV) is the most
advanced Ebola virus vaccine candidate and is currently being used to combat the outbreak …
advanced Ebola virus vaccine candidate and is currently being used to combat the outbreak …
Vesicular stomatitis virus: from agricultural pathogen to vaccine vector
G Liu, W Cao, A Salawudeen, W Zhu, K Emeterio… - Pathogens, 2021 - mdpi.com
Vesicular stomatitis virus (VSV), which belongs to the Vesiculovirus genus of the family
Rhabdoviridae, is a well studied livestock pathogen and prototypic non-segmented …
Rhabdoviridae, is a well studied livestock pathogen and prototypic non-segmented …